Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,678,136
  • Shares Outstanding, K 348,340
  • Annual Sales, $ 15,941 M
  • Annual Income, $ -4,125,500 K
  • 36-Month Beta 1.18
  • Price/Sales 3.65
  • Price/Cash Flow 4.15
  • Price/Book 0.80

Price Performance

See More
Period Period Low Period High Performance
1-Month
155.70 +6.35%
on 03/26/18
169.70 -2.43%
on 03/29/18
-3.38 (-2.00%)
since 03/16/18
3-Month
142.81 +15.94%
on 03/05/18
193.33 -14.35%
on 01/23/18
-14.06 (-7.83%)
since 01/18/18
52-Week
142.81 +15.94%
on 03/05/18
256.80 -35.52%
on 07/25/17
-68.80 (-29.35%)
since 04/18/17

Most Recent Stories

More News
Blog Exposure - Allergan to Officially Launch TrueTear(R) Device During 2018 ASCRS-ASOA Annual Meeting

LONDON, UK / ACCESSWIRE / April 17, 2018 / Active-Investors.com has just released a free research report on Allergan PLC (NYSE: ). If you want access to this report all you need to do is sign up now by...

AGN : 165.58 (-0.75%)
Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced the official launch of TrueTear®, the first and only FDA-cleared device developed to temporarily increase tear production...

AGN : 165.58 (-0.75%)
Look for Shares of Allergan Plc to Potentially Pullback after Yesterday's 1.09% Rise

Allergan Plc (NYSE:AGN) traded in a range yesterday that spanned from a low of $163.30 to a high of $166.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $164.71...

AGN : 165.58 (-0.75%)
FDA Prolongs Review Date for AbbVie Endometriosis Candidate

The FDA extends the review period of NDA for AbbVie (ABBV) and partner Neurocrine Biosciences' endometriosis candidate, elagolix, by three months to third-quarter 2018.

LGND : 170.28 (-0.45%)
AGN : 165.58 (-0.75%)
INFI : 2.19 (-1.35%)
ABBV : 94.32 (+0.78%)
Global Hyperhidrosis Therapeutics Pipeline Analysis Report 2017 with Key Players Dermira, Allergan and TheraVida Covered

The "Hyperhidrosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designations, Collaborations, and Other Developments" report has been added to ResearchAndMarkets.com's offering....

AGN : 165.58 (-0.75%)
Pharma Stock Roundup: LLY's Cyramza Shines in Cancer Study, PFE & AZN in Focus

Pfizer (PFE) inks new CAR-T deal, AstraZeneca (AZN) provides positive regulatory updates and Lilly's (LLY) Cyramza shows survival benefit in liver cancer study

AZN : 35.98 (+0.33%)
MRK : 58.92 (-0.59%)
LLY : 79.72 (-0.25%)
AGN : 165.58 (-0.75%)
PFE : 36.49 (+0.44%)
GSK : 40.44 (-0.17%)
BMY : 52.30 (-0.15%)
Global Biosimilars Markets to 2022 Featuring Profiles of Key Players - Allergan, Bioton, Cinnagen, Emcure Pharma, LG Life Sciences, Neuclone and Pfizer - ResearchAndMarkets.com

The "Biosimilars: Global Markets" report has been added to ResearchAndMarkets.com's offering.

AGN : 165.58 (-0.75%)
Allergan Presents Results From Global Survey Highlighting the Importance of Trust in Medical Aesthetics

Allergan Presents Results From Global Survey Highlighting the Importance of Trust in Medical Aesthetics

AGN : 165.58 (-0.75%)
Paratek's (PRTK) NDAs for Omadacycline Get Priority Review

Paratek Pharmaceuticals (PRTK) is seeking approval for its antibiotic candidate, omadacycline, for the treatment of CABP and ABSSSI in the United States.

BAYRY : 31.0800 (-0.35%)
AGN : 165.58 (-0.75%)
NBRV : 5.18 (-1.71%)
PRTK : 13.25 (-2.21%)
FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus

The FDA's refusal to review Alkermes' depression candidate AKLS 5461 has brought depression disease market in focus. Here we take a look at a few companies developing products for this market.

JNJ : 127.72 (-2.16%)
LLY : 79.72 (-0.25%)
AGN : 165.58 (-0.75%)
SAGE : 172.44 (+2.14%)
ALKS : 46.85 (+1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 168.43
1st Resistance Point 167.00
Last Price 165.58
1st Support Level 164.80
2nd Support Level 164.03

See More

52-Week High 256.80
Fibonacci 61.8% 213.26
Fibonacci 50% 199.80
Fibonacci 38.2% 186.35
Last Price 165.58
52-Week Low 142.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar